Position in ABBV
as of Jun 30, 2026
· filed Aug 7, 2026
Position Value
$2,178,447
+$234,522 QoQ
Shares Held
8,657
-3.1% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.62%
of 13F equity value
Holder Rank
#1,897
of 4,153 holders
Holding Since
Dec 2025
3 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Marble Wealth, LLC holds $9,145,988 across 8 Drug Manufacturers - General names. ABBV ranks #2 (23.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
10,610 | $2,694,621 | |
| 2 | ABBV |
AbbVie Inc.
This page
|
8,657 | $2,178,447 | |
| 3 | LLY |
ELI LILLY & Co
|
1,326 | $1,590,444 | |
| 4 | MRK |
Merck & Co., Inc.
|
10,741 | $1,380,218 | |
| 5 | AMGN |
Amgen Inc
|
1,077 | $390,003 | |
| 6 | AZN |
Astrazeneca PLC
|
1,643 | $311,545 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
5,356 | $308,612 | |
| 8 | GILD |
Gilead Sciences, Inc.
|
2,312 | $292,098 |
All Filings in ABBV
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,178,447 | 8,657 | Shares | Sole | 2026-08-07 | |
| 2026-03-31 | $1,943,925 | 8,938 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $4,068,721 | 17,807 | Shares | Sole | 2026-02-10 | |
| No filing history on record for this holder in this stock. | ||||||